SEC 13F Intelligence

Orion Investment Co / REGN

Orion Investment Co’s Regeneron Pharmaceuticals Position

Does Orion Investment Co own Regeneron Pharmaceuticals (REGN)? Yes — 30.8K shares worth $24M (+7.56% of its 13F portfolio) as of Q1 2026, up from 30.8K shares the prior filed quarter.

Position Value
$24M
Q1 2026
Shares
30.8K
% of Portfolio
+7.56%
Quarters Held
8
currently held

Position History REGN

Reported value by quarter
Q2 ’24: $31MQ2 ’24Q3 ’24: $31MQ3 ’24Q4 ’24: $21MQ4 ’24Q1 ’25: $19MQ1 ’25Q2 ’25: $16MQ2 ’25Q3 ’25: $17MQ3 ’25Q4 ’25: $24MQ4 ’25Q1 ’26: $24MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202630.8K$24M+7.56%
Q4 202530.8K$24M+7.25%
Q3 202530.6K$17M+5.47%
Q2 202530.3K$16M+5.63%
Q1 202530.6K$19M+7.92%
Q4 202429.9K$21M+8.49%
Q3 202429.4K$31M+12.01%
Q2 202429.5K$31M+12.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orion Investment Co’s full portfolio or all institutional holders of REGN.